Genetic Counseling for GBA1 Variants in Parkinson's Disease
Author Information
Author(s): Vieira Sophia R.L., Mezabrovschi Roxana, Toffoli Marco, Del Pozo Sara Lucas, Menozzi Elisa, Mullin Stephen, Yalkic Selen, Limbachiya Naomi, Koletsi Sofia, Loefflad Nadine, Lopez Grisel J., Gan‐Or Ziv, Alcalay Roy N., Sidransky Ellen, Schapira Anthony H.V.
Primary Institution: University College London
Hypothesis
How do GBA1 variants influence the risk of developing Parkinson's disease?
Conclusion
GBA1 variants are a significant genetic risk factor for Parkinson's disease, and effective genetic counseling is essential for affected individuals and their families.
Supporting Evidence
- GBA1 variants are the most common genetic risk factor for Parkinson's disease.
- Access to GBA1 testing is limited and varies by region.
- Genetic counseling can help clarify the implications of GBA1 variants for patients and their families.
- Ethical considerations are important in the context of genetic testing and counseling.
Takeaway
Some people have a gene change that can make them more likely to get Parkinson's disease, and it's important for doctors to help them understand what that means.
Methodology
The article reviews current knowledge and provides consensus recommendations for genetic counseling regarding GBA1 variants and their association with Parkinson's disease.
Potential Biases
Potential biases may arise from the variability in genetic counseling practices and the interpretation of GBA1 variant significance.
Limitations
Access to GBA1 testing and counseling varies globally, and there is a lack of standardized practices in communicating genetic risks.
Participant Demographics
The review discusses GBA1 variant carriers, particularly focusing on populations at risk, such as Ashkenazi Jews.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website